Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viveve Medical, Inc. (PLC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viveve Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 879682.
Total stock buying since 2014: $38,028,134.
Total stock sales since 2014: $970,291.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 89,600 | $513,612 | 199,997 | $970,291 | 0 | $0 |
| 2017 | 2,142,500 | $8,576,250 | 0 | $0 | 0 | $0 |
| 2016 | 2,639,516 | $13,188,998 | 0 | $0 | 0 | $0 |
| 2015 | 15,750,430 | $7,606,890 | 0 | $0 | 0 | $0 |
| 2014 | 15,362,994 | $8,142,384 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-10 | 0 | $0 | 23,688 | $131,705 | 0 | $0 |
| 2019-09 | 89,600 | $513,612 | 176,309 | $838,586 | 0 | $0 |
| 2017-08 | 5,000 | $26,250 | 0 | $0 | 0 | $0 |
| 2017-03 | 2,137,500 | $8,550,000 | 0 | $0 | 0 | $0 |
| 2016-06 | 2,637,500 | $13,187,500 | 0 | $0 | 0 | $0 |
| 2016-02 | 588 | $499 | 0 | $0 | 0 | $0 |
| 2016-01 | 1,428 | $999 | 0 | $0 | 0 | $0 |
| 2015-12 | 1,359 | $998 | 0 | $0 | 0 | $0 |
| 2015-11 | 5,339,043 | $3,737,389 | 0 | $0 | 0 | $0 |
| 2015-08 | 1,052 | $999 | 0 | $0 | 0 | $0 |
| 2015-06 | 30,600 | $27,509 | 0 | $0 | 0 | $0 |
| 2015-05 | 10,378,376 | $3,839,995 | 0 | $0 | 0 | $0 |
| 2014-09 | 15,362,994 | $8,142,384 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-01 | Goldman Sachs & Co. Llc | Sale | 23,688 | 5.56 | 131,705 |
| 2019-09-01 | Goldman Sachs & Co. Llc | Buy | 64,200 | 5.75 | 370,102 |
| 2019-09-01 | Goldman Sachs & Co. Llc | Sale | 93,554 | 5.46 | 449,692 |
| 2017-08-23 | Durbin Scott (Chief Financial Officer) | Buy | 5,000 | 5.25 | 26,250 |
| 2017-03-17 | Atkinson James G. (CBO & President) | Buy | 375,000 | 4.00 | 1,500,000 |
| 2017-03-17 | Scheller Patricia (Chief Executive Officer) | Buy | 12,500 | 4.00 | 50,000 |
| 2017-03-17 | Lynch Timothy P | Buy | 1,250,000 | 4.00 | 5,000,000 |
| 2017-03-17 | Janney Daniel (Director) | Buy | 500,000 | 4.00 | 2,000,000 |
| 2016-06-17 | Atkinson James G. (CBO & President) | Buy | 300,000 | 5.00 | 1,500,000 |
| 2016-06-17 | Scheller Patricia (Chief Executive Officer) | Buy | 18,000 | 5.00 | 90,000 |
| 2016-06-17 | Durbin Scott (Chief Financial Officer) | Buy | 4,500 | 5.00 | 22,500 |
| 2016-06-17 | Lynch Timothy P (10% Owner) | Buy | 900,000 | 5.00 | 4,500,000 |
| 2016-06-17 | Janney Daniel (Director) | Buy | 400,000 | 5.00 | 2,000,000 |
| 2016-02-25 | Scheller Patricia (Chief Executive Officer) | Buy | 588 | .85 | 499 |
| 2016-01-25 | Scheller Patricia (Chief Executive Officer) | Buy | 1,428 | .70 | 999 |
| 2015-12-23 | Scheller Patricia (Chief Executive Officer) | Buy | 1,359 | .73 | 998 |
| 2015-11-24 | Atkinson James G. (CBO & President) | Buy | 751,962 | .70 | 526,373 |
| 2015-11-24 | Alta Bioequities, L.p. (10% Owner) | Buy | 857,142 | .70 | 599,999 |
| 2015-11-24 | Scheller Patricia (Chief Executive Officer) | Buy | 14,285 | .70 | 9,999 |
| 2015-11-24 | Stonepine Capital, L.p. | Buy | 2,857,142 | .70 | 1,999,999 |
| 2015-11-24 | Janney Daniel (Director) | Buy | 857,142 | .70 | 599,999 |
| 2015-11-17 | Scheller Patricia (Chief Executive Officer) | Buy | 1,370 | .74 | 1,020 |
| 2015-08-05 | Scheller Patricia (Chief Executive Officer) | Buy | 1,052 | .95 | 999 |
| 2015-06-12 | Atkinson James G. (CBO & President) | Buy | 30,600 | .90 | 27,509 |
| 2015-05-14 | Colella Mark Samuel (Director) | Buy | 675,675 | .37 | 249,999 |
| 2015-05-14 | Rocklage Scott M (10% Owner) | Buy | 675,675 | .37 | 249,999 |
| 2015-05-12 | Atkinson James G. (CBO & President) | Buy | 3,378,377 | .37 | 1,249,999 |
| 2015-05-12 | Alta Bioequities, L.p. (10% Owner) | Buy | 2,702,702 | .37 | 999,999 |
| 2015-05-12 | Scheller Patricia (Chief Executive Officer) | Buy | 135,136 | .37 | 50,000 |
| 2015-05-12 | Durbin Scott (Chief Financial Officer) | Buy | 40,541 | .37 | 15,000 |
| 2015-05-12 | Robbins Jim B (Vice President of Finance) | Buy | 67,568 | .37 | 25,000 |
| 2015-05-12 | Janney Daniel (Director) | Buy | 2,702,702 | .37 | 999,999 |
| 2014-09-23 | Colella Mark Samuel | Buy | 5,215,664 | .53 | 2,764,301 |
| 2014-09-23 | Smith Brigitte (Director) | Buy | 1,140,134 | .53 | 604,271 |
| 2014-09-23 | Gbs Bioventures Iii A/c (10% Owner) | Buy | 1,895,744 | .53 | 1,004,744 |
| 2014-09-23 | Diekman John D | Buy | 5,215,664 | .53 | 2,764,301 |
| 2014-09-23 | Janney Daniel (Director) | Buy | 1,895,788 | .53 | 1,004,767 |
Insider trading activities including stock purchases, stock sales, and option exercises of PLC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viveve Medical, Inc. (symbol PLC, CIK number 879682) see the Securities and Exchange Commission (SEC) website.